← Back to Search

Contrast-Enhanced Ultrasound for Breast Cancer

Q: In what ways is Perflutren Lipid Microcpheres commonly applied?

Perflutren Lipid Microcpheres are the go-to treatment for echocardiography. Additionally, they can be useful in managing <a href="https://www.withpower.com/clinical-trials/cardiovascular">cardiovascular</a> diseases, aiding diagnostic imaging processes, and providing insight into left ventricular structure.

Q: Are there available slots for individuals seeking to partake in this trial?

Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial is actively searching for participants and was initially posted on November 24th 2020. 25 patients need to be recruited from 1 centre of care.

Q: How many participants are participating in this investigation?

Yes, clinicaltrials.gov confirms that this medical study is actively seeking participants; the trial was initially launched on November 24th 2020 and has been updated as recently as August 1st 2022. It seeks to enrol 25 patients at a single site.

Q: Are there extant research efforts that have focused upon Perflutren Lipid Microcpheres?

Presently, 19 clinical studies are investigating the efficacy of Perflutren Lipid Microcpheres. Of those investigations, one is currently in Phase 3. Philadelphia, <a href="https://www.withpower.com/clinical-trials/pennsylvania">Pennsylvania</a> serves as a major site for this research but there are 26 total sites active in conducting trials related to this treatment.

Phase < 1

Recruiting

Research Sponsored by Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline

Awards & highlights

Study Summary

This trial will use ultrasound to estimate tissue pressure in breast cancer patients. The hope is that this will be a less invasive way to get this information.

Who is the study for?

This trial is for adults over 21 with breast cancer who are medically stable and have a mass in the breast suitable for biopsy. They must be able to follow study procedures, not be pregnant or nursing, and have no severe illnesses or recent surgeries.Check my eligibility

What is being tested?

The trial studies how well contrast-enhanced ultrasound can estimate tissue pressure in the breast noninvasively. It involves using an ultrasound with a special contrast agent called Perflutren Lipid Microspheres.See study design

What are the potential side effects?

Potential side effects may include allergic reactions to the contrast agent used during the ultrasound procedure. However, serious side effects are rare.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation between subharmonic aided pressure estimation (SHAPE) results and direct measurements of interstitial fluid pressure (IFP)

Secondary outcome measures

Prediction of malignancy of breast tumor by the 3-dimensional subharmonic aided pressure estimation results

Trial Design

1Treatment groups

Experimental Treatment

Group I: Diagnostic (CEUS)Experimental Treatment3 Interventions

Patients undergo ultrasound without contrast. Patients then receive Definity IV over 15 minutes and undergo CEUS.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor

445 Previous Clinical Trials

145,689 Total Patients Enrolled

5 Trials studying Breast Cancer

607 Patients Enrolled for Breast Cancer

Media Library

Contrast-Enhanced Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT04721886 — Phase < 1

Breast Cancer Research Study Groups: Diagnostic (CEUS)

Breast Cancer Clinical Trial 2023: Contrast-Enhanced Ultrasound Highlights & Side Effects. Trial Name: NCT04721886 — Phase < 1

Contrast-Enhanced Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT04721886 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In what ways is Perflutren Lipid Microcpheres commonly applied?

"Perflutren Lipid Microcpheres are the go-to treatment for echocardiography. Additionally, they can be useful in managing cardiovascular diseases, aiding diagnostic imaging processes, and providing insight into left ventricular structure."

Answered by AI

Are there available slots for individuals seeking to partake in this trial?

"Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial is actively searching for participants and was initially posted on November 24th 2020. 25 patients need to be recruited from 1 centre of care."

Answered by AI

How many participants are participating in this investigation?

"Yes, clinicaltrials.gov confirms that this medical study is actively seeking participants; the trial was initially launched on November 24th 2020 and has been updated as recently as August 1st 2022. It seeks to enrol 25 patients at a single site."

Answered by AI

Are there extant research efforts that have focused upon Perflutren Lipid Microcpheres?

"Presently, 19 clinical studies are investigating the efficacy of Perflutren Lipid Microcpheres. Of those investigations, one is currently in Phase 3. Philadelphia, Pennsylvania serves as a major site for this research but there are 26 total sites active in conducting trials related to this treatment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

2020. "Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04721886.